Last reviewed · How we verify
NCT02041039
Reward System Responses to Food Aromas
trial in Adiposity in 332 participants. Completed in 11 September 2015.
11 September 2015
Quick facts
| Lead sponsor | Robert Considine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 332 |
| Start date | 15 April 2011 |
| Primary completion | 11 September 2015 |
| Estimated completion | 11 September 2015 |
| Sites | 1 location across United States |
Conditions studied
- Adiposity — all drugs for Adiposity →
Sponsor
Robert Considine
Who can join
Adults 18 to 40, female only, with Adiposity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Food aromas are a part of foods' flavor, and can promote overeating. Alcohol consumption also stimulates appetite, and contributes to overeating while under alcohol's acute effects. Knowing the brain regions that respond to food aromas and alcohol, and how they are modified by the amount of body fat and alcohol exposure, will provide critical information about the neural systems that underlie loss of control of eating. Therefore, the main hypotheses of this study are that: A) Lean and obese subjects have different brain responses to food aromas that enhance desire to eat, and B) Acute alcohol intoxication i) enhances the brain's response to food odors, and ii) affects brain systems that inhibit or terminate eating. To test these hypotheses, we have modified functional magnetic resonance imaging (fMRI) paradigms successfully used to study alcoholic drink aromas in subjects at risk for alcoholism.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ventral frontal satiation-mediated responses to food aromas in obese and normal-weight women.
Eiler WJ, Dzemidzic M, Case KR, Armstrong CL, et al · · 2014 · cited 14× · PMID 24695888 · DOI 10.3945/ajcn.113.080788
Verify or expand the search:
- PubMed search for NCT02041039
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adiposity
Currently open trials in the same condition.
- NCT06532747 — Redefining BMI: The Body, Mind, and Inflammation Trial · NA · recruiting
- NCT07103343 — MOVI-OLE! [Open Learning Environments] · NA · active not recruiting
- NCT06264882 — Cardiometabolic Consequences of the Loss of Ovarian Function · Phase 4 · recruiting
- NCT06208345 — Early Life Intervention in Pediatrics Supported by E-health · NA · recruiting
- NCT06129110 — Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02041039 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Robert Considine
- Last refreshed: 11 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02041039.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing